Comments on: Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test http://currents.plos.org/genomictests/article/fecal-dna-testing-for-colorectal-cancer-od1hzthyodr3-1/ Tue, 12 May 2015 07:52:06 +0000 hourly 1 http://wordpress.org/?v=4.2.2 By: Narayana Rao http://currents.plos.org/genomictests/article/fecal-dna-testing-for-colorectal-cancer-od1hzthyodr3-1/#comment-3 Fri, 10 Jun 2011 19:26:59 +0000 http://currents.plos.org/genomictests/article/fecal-dna-testing-for-colorectal-cancer-od1hzthyodr3-1/#comment-3 Added the knol to top knols of 2011 collection — http://knol.google.com/k/-/-/2utb2lsm2k7a/2387You need to add categories to your knol. You can add Health and Science as main categories.

]]>
By: Alisha Lopej http://currents.plos.org/genomictests/article/fecal-dna-testing-for-colorectal-cancer-od1hzthyodr3-1/#comment-5 Thu, 12 May 2011 23:16:55 +0000 http://currents.plos.org/genomictests/article/fecal-dna-testing-for-colorectal-cancer-od1hzthyodr3-1/#comment-5 Colorectal cancer — Today, several test are available to colorectal cancer. When a patient shows the symptoms of this cancer, his or her doctor can screen for the disease using one of several tests such as Fecal Occult Blood Test, Flexible-Sigmoidoscopy, Double Contrast Barium Enema, Colonoscopy and DNA-Based stool test. A current study shows that a simple urine test can also detect this caner. http://www.justcancer.org/colorectal-cancer-urine-test-fine-tunes-simplifies-earlier-disease-detection.html

]]>
By: sergio stagnaro http://currents.plos.org/genomictests/article/fecal-dna-testing-for-colorectal-cancer-od1hzthyodr3-1/#comment-7 Wed, 20 Apr 2011 08:34:06 +0000 http://currents.plos.org/genomictests/article/fecal-dna-testing-for-colorectal-cancer-od1hzthyodr3-1/#comment-7 Colon Cancer screening? Why not Colon Cancer Primary Prevention? — Some years ago, the health secretary, John Reid, announced a national screening programme for bowel cancer, introduced in England from April 2006 (1). Unfortunately, however, such screening was carried out in “all” individuals over 40 years old, and was based as usually on faecal occult blood testing, which looks for blood in stool samples, and flexible sigmoidoscopy, which could allow careful examination of the bowel. I foresaw that also that screening would be resulted an expensive flop, like that based on CT scanning, since World Health Authorities, in England as well as in Italy, overlook the real existence of Oncological Terrain-Dependent, Inherited Real Risk, e.g., of bowel cancer (2). In fact, I described formerly a lot of biophysical-semeiotic constitutions, among them oncological constitution (2, 6-9) As regards bowel cancer primary prevention, I can state what recently wrote on the “clinical” war against gastric cancer (4, 9), wherein I illustrated my personal “Weltanshauung”, based on 55 year long clinical experience, illustrating a clinical sign: Berretti’s Sign. Really, screening, even correctly, as well as rationally implemented, i.e., exclusively in individuals affected by both Oncological Terrain-Dependent Inherited Real Risk, is remarkable and price-worthy, but primary prevention is better for people (5, 6-13). In conclusion, aiming to defeat Colon Cancer we need a clinical tool, which allows us to bedside recognize individuals involved by real inherited risk, to enrol in primary prevention .Sergio Stagnarowww.semeioticabiofisica.it References1) Mayor S. England to start national bowel cancer screening programme BMJ 2004;329:1061 (6 November), doi:10.1136/bmj.329.7474.1061-a 2) Stagnaro Sergio, Stagnaro-Neri Marina. Introduzione alla Semeiotica Biofisica. Il Terreno oncologico. Travel Factory SRL., Roma, 2004. http://www.travelfactory.it/semeiotica_biofisica.htm 3) Stagnaro S., Stagnaro-Neri M., Le Costituzioni Semeiotico- Biofisiche.Strumento clinico fondamentale per la prevenzione primaria e la definizione della Single Patient Based Medicine. Ediz. Travel Factory, Roma, 2004. 4) Stagnaro S. Oncological terrain plays a paramount role in the war against gastric cancer. http://www.biomedcentral.com/1471- 230X/4/28/comments#87454 5) Stagnaro S., Stagnaro-Neri M., La Melatonina nella Terapia del Terreno Oncologico e del Reale Rischio Oncologico. Ediz. Travel Factory, Roma, 2004.6) Stagnaro Sergio. Reale Rischio Semeiotico Biofisico. I Dispositivi Endoarteriolari di Blocco neoformati, patologici, tipo I, sottotipo a) oncologico, e b) aspecifico. Ediz. Travel Factory, http://www.travelfactory.it, Roma, Luglio 2009.7) Stagnaro Sergio. Colon Cancer Oncological Terrain-Dependent Inherited Real Risk. Ann. Int. Med. (15 April 2009), http://www.annals.org/cgi/eletters/150/7/4658) Stagnaro Sergio. Single Patient Based Medicine: its paramount role in Future Medicine. Public Library of Science. http://www.plosmedicine.org/annotation/listThread.action?inReplyTo=info:doi/10.1371/annotation/0e440745-6bfb-4690-a0c9-92b77057b539&root=info:doi/10.1371/annotation/0e440745-6bfb-4690-a0c9-92b77057b539 9) Sergio Stagnaro. Segno di Berretti: Diagnosi Semeiotica-Biofisica-Quantistica del Cancro Colon-Rettale, ad Iniziare Dal Reale Rischio Congenito. http://www.altrogiornale.org, 9 aprile 2010. http://www.altrogiornale.org/news.php?extend.598310) Simone Caramel and Sergio Stagnaro (2011) The role of glycocalyx in QBS diagnosis of Di Bella’s Oncological Terrain – http://www.sisbq.org/uploads/5/6/8/7/5687930/oncological_glycocalyx2011.pdf12) Simone Caramel and Sergio Stagnaro (2011) Quantum Biophysical Semeiotics of Oncological Inherited Real Risk of Myelopathy: The diagnostic role of glycocalyx. http://www.sisbq.org/uploads/5/6/8/7/5687930/qbs_myelopathy_glycocalyx_english.pdf13) Simone Caramel and Sergio Stagnaro (2011) Quantum Biophysical Semeiotics and mit-Genome’s fractal dimension Journal of Quantum Biophysical Semeiotics, 1 1-27,http://www.sisbq.org/uploads/5/6/8/7/5687930/joqbs_mitgenome.pdf

]]>